{
    "startDate": "2018-01-01",
    "endDate": "2018-03-31",
    "year": "2018",
    "quarter": "Q1",
    "symbol": "IONS",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 227505000
            },
            {
                "label": "Short-term investments",
                "concept": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
                "unit": "usd",
                "value": 807796000
            },
            {
                "label": "Contracts receivable",
                "concept": "ContractWithCustomerAssetNetCurrent",
                "unit": "usd",
                "value": 36858000
            },
            {
                "label": "Inventories",
                "concept": "InventoryRawMaterialsNetOfReserves",
                "unit": "usd",
                "value": 9060000
            },
            {
                "label": "Other current assets",
                "concept": "OtherAssetsCurrent",
                "unit": "usd",
                "value": 62064000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 1143283000
            },
            {
                "label": "Property, plant and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 123188000
            },
            {
                "label": "Patents, net",
                "concept": "FiniteLivedIntangibleAssetsNet",
                "unit": "usd",
                "value": 22914000
            },
            {
                "label": "Deposits and other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 10175000
            },
            {
                "label": "Total",
                "concept": "Assets",
                "unit": "usd",
                "value": 1299560000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 13833000
            },
            {
                "label": "Accrued compensation",
                "concept": "EmployeeRelatedLiabilitiesCurrent",
                "unit": "usd",
                "value": 12166000
            },
            {
                "label": "Accrued liabilities",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 66470000
            },
            {
                "label": "Current portion of deferred contract revenue",
                "concept": "ContractWithCustomerLiabilityCurrent",
                "unit": "usd",
                "value": 120127000
            },
            {
                "label": "Accrued liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 212643000
            },
            {
                "label": "Long-term deferred contract revenue",
                "concept": "ContractWithCustomerLiabilityNoncurrent",
                "unit": "usd",
                "value": 85446000
            },
            {
                "label": "1 percent convertible senior notes",
                "concept": "ConvertibleDebtNoncurrent",
                "unit": "usd",
                "value": 541635000
            },
            {
                "label": "Long-term mortgage debt",
                "concept": "LongTermLoansFromBank",
                "unit": "usd",
                "value": 59789000
            },
            {
                "label": "Accrued liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 912459000
            },
            {
                "label": "Common stock, $0.001 par value; 300,000,000 shares authorized, 125,448,746 and 124,976,373 shares issued and outstanding at March 31, 2018 and December 31, 2017, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 125000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 1576954000
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -33234000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -1242454000
            },
            {
                "label": "Total liabilities and stockholders' equity",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 301391000
            },
            {
                "label": "Income (loss) before income tax expense",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": 85710000
            },
            {
                "label": "Beginning balance",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 387101000
            },
            {
                "label": "Total liabilities and stockholders' equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 1299560000
            }
        ],
        "cf": [
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -10812000
            },
            {
                "label": "Depreciation",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 2363000
            },
            {
                "label": "Amortization of premium on investments, net",
                "concept": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
                "unit": "usd",
                "value": -1192000
            },
            {
                "label": "Amortization of debt issuance costs",
                "concept": "AmortizationOfFinancingCosts",
                "unit": "usd",
                "value": 441000
            },
            {
                "label": "Amortization of convertible senior notes discount",
                "concept": "AmortizationOfDebtDiscountPremium",
                "unit": "usd",
                "value": 8083000
            },
            {
                "label": "Amortization of long-term financing liability for leased facility",
                "concept": "AmortizationOfLeasedAsset",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Stock-based compensation expense",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 28451000
            },
            {
                "label": "Non-cash losses related to patents, licensing and property, plant and equipment",
                "concept": "AssetImpairmentCharges",
                "unit": "usd",
                "value": 175000
            },
            {
                "label": "Inventories",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": -922000
            },
            {
                "label": "Other current and long-term assets",
                "concept": "IncreaseDecreaseInOtherOperatingAssets",
                "unit": "usd",
                "value": -11422000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": -13144000
            },
            {
                "label": "Accrued compensation",
                "concept": "IncreaseDecreaseInOtherEmployeeRelatedLiabilities",
                "unit": "usd",
                "value": -12985000
            },
            {
                "label": "Operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": 13165000
            },
            {
                "label": "Purchases of short-term investments",
                "concept": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
                "unit": "usd",
                "value": 91157000
            },
            {
                "label": "Proceeds from the sale of short-term investments",
                "concept": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
                "unit": "usd",
                "value": 173724000
            },
            {
                "label": "Research and Development Facility [Abstract]",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 2343000
            },
            {
                "label": "Proceeds from the sale of Regulus Therapeutics stock",
                "concept": "ProceedsFromSaleOfEquityMethodInvestments",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": 79486000
            },
            {
                "label": "Proceeds from equity awards",
                "concept": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
                "unit": "usd",
                "value": 5675000
            },
            {
                "label": "Proceeds from the issuance of common stock to Novartis",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Stock issuance costs paid",
                "concept": "PaymentsOfStockIssuanceCosts",
                "unit": "usd",
                "value": 451000
            },
            {
                "label": "Principal payments on debt and capital lease obligations",
                "concept": "RepaymentsOfLongTermDebtAndCapitalSecurities",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Net cash provided by financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 5224000
            },
            {
                "label": "Net increase in cash and cash equivalents",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": 97875000
            },
            {
                "label": "Interest paid",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": 644000
            }
        ],
        "ic": [
            {
                "label": "Revenue earned",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 144419000
            },
            {
                "label": "Selling, General and Administrative [Member]",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 43653000
            },
            {
                "label": "Expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 147720000
            },
            {
                "label": "Income (loss) from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -3301000
            },
            {
                "label": "Investment income",
                "concept": "InvestmentIncomeNet",
                "unit": "usd",
                "value": 3610000
            },
            {
                "label": "Interest expense",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 10938000
            },
            {
                "label": "Other expenses",
                "concept": "OtherNonoperatingExpense",
                "unit": "usd",
                "value": 168000
            },
            {
                "label": "Income (loss) before income tax expense",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -10797000
            },
            {
                "label": "Income tax expense",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 15000
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -10812000
            },
            {
                "label": "Net loss attributable to noncontrolling interest in Akcea Therapeutics, Inc.",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -9392000
            },
            {
                "label": "Adjustments to reconcile net income (loss) to net cash provided by operating activities:",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -1420000
            },
            {
                "label": "Basic Net Income (Loss) per Share [Abstract]",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": -0.01
            },
            {
                "label": "Shares used in computing basic net income (loss) per share (in shares)",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 125330000
            },
            {
                "label": "Diluted net income per share (in dollars per share)",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": -0.01
            },
            {
                "label": "Shares used in computing diluted net income (loss) per share (in shares)",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 125330000
            },
            {
                "label": "Unrealized gains (losses) on debt securities, net of tax",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": -1530000
            },
            {
                "label": "Reclassification adjustment for realized gains included in net income (loss)",
                "concept": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Currency translation adjustment",
                "concept": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": 55000
            },
            {
                "label": "Comprehensive income (loss)",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -12287000
            },
            {
                "label": "Comprehensive loss attributable to noncontrolling interests",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -9423000
            },
            {
                "label": "Comprehensive loss attributable to noncontrolling interests",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -2864000
            }
        ]
    }
}